ArticleBMC cancer2018

Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report.

Masayuki Tori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.